ABS Direct Equity Fund’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Sell
150
-2,150
-93% -$234K 0.22% 83
2026
Q1
$210K Buy
+2,300
New +$231K 0.16% 76

Other funds holding GH

ABS Direct Equity Fund's GH Position: Q2 2026 in Review

ABS Direct Equity Fund reduced its Guardant Health (GH) stake by 93% in Q2 2026, selling an estimated $234K and leaving 150 shares worth $345K. The position accounts for 0.22% of the portfolio, ranked #83.

ABS Direct Equity Fund first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • ABS Direct Equity Fund held 150 shares of Guardant Health worth $345K as of Q2 2026.
  • ABS Direct Equity Fund sold 2,150 Guardant Health shares in Q2 2026, an estimated $234K.
  • Guardant Health made up 0.22% of ABS Direct Equity Fund's portfolio in Q2 2026, its #83 holding.
  • ABS Direct Equity Fund first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on ABS Direct Equity Fund's 13F filing for Q2 2026, filed 13 Aug 2026.